Literature DB >> 17465502

No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples.

Lili Magyari1, Bernadett Faragó, Judit Bene, Katalin Horvatovich, Lilla Lakner, Márta Varga, Mária Figler, Beáta Gasztonyi, Gyula Mózsik, Béla Melegh.   

Abstract

AIM: The goal of the current work was to analyse the prevalence of the +49A/G variant of the cytotoxic T-lymphocyte antigen 4 gene (CTLA4) in Hungarian patients with Crohnos disease (CD) and ulcerative colitis (UC).
METHODS: A total of 130 unrelated subjects with CD and 150 with UC, and 170 matched controls were genotyped for the single nucleotide polymorphism (SNP). The genotypes were determined by using PCR/RFLP test.
RESULTS: The G allele frequency and the prevalence of the GG genotype were 38.1% and 12.3% in the CD group, 40.6% and 18.6% in the UC patients, and 37.4% and 15.9% in the control group, respectively.
CONCLUSION: The results of the current study show that carriage of the +49G SNP in heterozygous or in homozygous form does not confer risk either for CD or for UC in the Hungarian population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465502      PMCID: PMC4146845          DOI: 10.3748/wjg.v13.i15.2205

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders.

Authors:  A T Naluai; S Nilsson; L Samuelsson; A H Gudjónsdóttir; H Ascher; J Ek; B Hallberg; B Kristiansson; T Martinsson; O Nerman; L M Sollid; J Wahlström
Journal:  Tissue Antigens       Date:  2000-10

2.  [Alteration of nationality structure in the Carpathian Basin].

Authors:  I Hooz
Journal:  Stat Szle       Date:  1996-11

Review 3.  Inflammatory bowel disease (2)

Authors:  D K Podolsky
Journal:  N Engl J Med       Date:  1991-10-03       Impact factor: 91.245

4.  Trading genes along the silk road: mtDNA sequences and the origin of central Asian populations.

Authors:  D Comas; F Calafell; E Mateu; A Pérez-Lezaun; E Bosch; R Martínez-Arias; J Clarimon; F Facchini; G Fiori; D Luiselli; D Pettener; J Bertranpetit
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

5.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

6.  Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese.

Authors:  Haruhisa Machida; Kazuhiro Tsukamoto; Chun-Yang Wen; Yukiko Narumi; Saburou Shikuwa; Hajime Isomoto; Fuminao Takeshima; Yohei Mizuta; Norio Niikawa; Ikuo Murata; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

7.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

8.  The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.

Authors:  V Suppiah; I Alloza; S Heggarty; A Goris; B Dubois; H Carton; K Vandenbroeck
Journal:  J Neuroimmunol       Date:  2005-07       Impact factor: 3.478

9.  No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter(-318) genes with rheumatoid arthritis in the Korean population.

Authors:  Young Ho Lee; Seong Jai Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Scand J Rheumatol       Date:  2002       Impact factor: 3.641

10.  Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese.

Authors:  C-S Lee; Y-J Lee; H-F Liu; C-H Su; S-C Chang; B-R Wang; T-L Chen; T-L Liu
Journal:  Clin Rheumatol       Date:  2003-09       Impact factor: 2.980

View more
  7 in total

1.  Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients.

Authors:  Veronika Csöngei; Luca Járomi; Eniko Sáfrány; Csilla Sipeky; Lili Magyari; Noémi Polgár; Judit Bene; Patrícia Sarlós; Lilla Lakner; Eszter Baricza; Melinda Szabó; Gábor Rappai; Béla Melegh
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

Review 2.  Gatekeepers of intestinal inflammation.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Inflamm Res       Date:  2010-01       Impact factor: 4.575

Review 3.  CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Authors:  Jia-Jun Zhao; Di Wang; Hui Yao; Da-Wei Sun; Hong-Yu Li
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

Review 4.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases.

Authors:  Alfred Balasa; Grace Gathungu; Peter Kisfali; E O'Brian Smith; Judy H Cho; Bela Melegh; Richard Kellermayer
Journal:  Int J Colorectal Dis       Date:  2010-02-02       Impact factor: 2.571

6.  The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease.

Authors:  Ondrej Hradsky; Petra Dusatkova; Martin Lenicek; Jiri Bronsky; Jiri Nevoral; Libor Vitek; Milan Lukas; Ivana Zeniskova; Ondrej Cinek
Journal:  BMC Med Genet       Date:  2010-06-10       Impact factor: 2.103

7.  Cytotoxic T lymphocyte antigen-4 promoter -658CT gene polymorphism is associated with ulcerative colitis in Chinese patients.

Authors:  Yan Luo; Bing Xia; Chun Li; Zhitao Chen; Liuqing Ge; Ting Jiang; Feng Zhou; Yan Zhao
Journal:  Int J Colorectal Dis       Date:  2008-12-16       Impact factor: 2.571

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.